Advance Health Mobile APP for the Self Management of Diabetes Type2

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

1600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-05

Study Completion Date

2025-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Digital health using mobile health (mHealth) tools, such as telehealth and text messaging, and or mobile Apps can improve blood glucose levels in patients with type 2 diabetes. This intervention is designed to improve self-management of diabetes and blood glucose levels in diabetic patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of an mHealth Mobile App

NCT06387433

Type II Diabetes

ACTIVE_NOT_RECRUITING NA

Diabetic Care Self-Management Mobile Health Application Among Diabetes Mellitus Clients in Malaysia

NCT04260100

Diabetes Mellitus, Type 2

COMPLETED NA

Just-In-Time Adaptive Interventions for Diabetic Patients

NCT06466837

Diabetes Self-Control Telemedicine

RECRUITING NA

Effectiveness of Health Management of Glycemic Control and Physical Activity in Type 2 Diabetes Mellitus Using Smartphone Application

NCT04631159

To Investigate the Effectiveness of Health Management of Glycemic Control and Physical Activity in Type 2 Diabetes Mellitus Using Smartphone Application

UNKNOWN NA

Examining the Effect of Mobile Application on Insulin Use Perception and Self-Management

NCT06060743

Type 2 Diabetes Treated With Insulin

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with type 2 diabetes may experience improvements in their blood glucose levels thanks to mHealth technologies like mobile apps and telehealth text messaging. The goal of this intervention is to help diabetic people better control their blood glucose levels and diabetes. The intervention arm will employ a smartphone application designed specifically for individuals with Type 2 diabetes, with the goal of improving their self-management behaviors. Features of the app include real-time health monitoring, appointment scheduling, medication tracking, patient data storage, treatment and follow-up recommendations, and health education and promotion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two-arm randomized control trial

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Participants and Investigators are blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention arm

Ae mobile application tailored for patients with Type 2 diabetes, aiming to enhance their self-management practices will be used for the intervention arm. The app includes features such as medication tracking, appointment scheduling, patient data storage, advice for treatment and follow-ups, health education and promotion, and real-time health monitoring.

Group Type EXPERIMENTAL

Diabetes self management @ click

Intervention Type BEHAVIORAL

A mobile application tailored for patients with Type 2 diabetes, aiming to enhance their self-management practices will be used for the intervention arm. The app includes features such as medication tracking, appointment scheduling, patient data storage, advice for treatment and follow-ups, health education and promotion, and real-time health monitoring.

Control arm

The control arm will be given no intervention except usual care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diabetes self management @ click

A mobile application tailored for patients with Type 2 diabetes, aiming to enhance their self-management practices will be used for the intervention arm. The app includes features such as medication tracking, appointment scheduling, patient data storage, advice for treatment and follow-ups, health education and promotion, and real-time health monitoring.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The presence of T2D and at least 1 recorded HbA1c level of 8.0% or higher in the past 6 months
* Age between ages 21 and 85 years,
* Receiving primary care at the clinical site
* Having fluency in English/ Urdu in reading and writing
* Having a smartphone
* Agreeing to take part in the study

Exclusion Criteria

* Planning to move away from the study site
* Being pregnant or in lactation, (6) being unable to send or read text messages on a mobile phone,
* Having a history of receiving or planning surgery.

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No